Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Cancer cell·2026
Same author

Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.

Blood cancer discovery·2026
Same author

LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Blood advances·2026
Same author

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.

Blood advances·2026
Same author

RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Axes of biological variation in diffuse large B cell lymphoma.

Cancer cell·2026

Related Experiment Video

Updated: Jul 19, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Gene expression profiling of lymphoid malignancies.

Louis M Staudt1

  • 1Metabolism Branch, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, Maryland 20892, USA. lstaudt@mail.nih.gov

Annual Review of Medicine
|January 31, 2002
PubMed
Summary

Gene expression profiling classifies cancers, revealing diffuse large B cell lymphoma (DLBCL) as two distinct diseases and chronic lymphocytic leukemia (CLL) as one, with subtypes impacting treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Gene expression profiling offers molecular classification for cancer, enabling homogeneous categorization based on pathogenesis and clinical behavior.
  • DNA microarrays facilitate comprehensive gene expression analysis, crucial for understanding cancer heterogeneity.

Purpose of the Study:

  • To classify cancers at a molecular level using gene expression profiling.
  • To investigate the molecular subtypes and pathogenesis of diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL).

Main Methods:

  • Utilized DNA microarrays for comprehensive gene expression profiling.
  • Analyzed gene expression signatures to differentiate cancer subtypes and identify molecular mechanisms.

More Related Videos

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
10:23

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations

Published on: January 19, 2017

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Related Experiment Videos

Last Updated: Jul 19, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
10:23

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations

Published on: January 19, 2017

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Main Results:

  • Diffuse large B cell lymphoma (DLBCL) comprises at least two distinct molecular subtypes with different B cell differentiation origins and clinical outcomes.
  • Chronic lymphocytic leukemia (CLL) presents as a single disease but exhibits two clinically divergent subtypes, with B cell antigen receptor signaling implicated in aggressive forms.
  • Gene expression analysis elucidated lymphomagenesis from BCL-6 translocations, identifying the NF-kappa B pathway as a therapeutic target in DLBCL.

Conclusions:

  • Gene expression profiling is a powerful tool for molecular cancer classification and understanding disease heterogeneity.
  • Distinct molecular subtypes within DLBCL and CLL necessitate tailored therapeutic strategies.
  • The NF-kappa B signaling pathway represents a promising therapeutic target for DLBCL.